6-Feb-2026
TipRanks (Tue, 3-Feb 8:48 AM ET)
Alexandria Real Estate Equities, Inc. Announces Cash Tender Offers
PRNewswire (Tue, 27-Jan 7:16 PM ET)
PRNewswire (Mon, 26-Jan 4:10 PM ET)
Globe Newswire (Mon, 26-Jan 10:48 AM ET)
Globe Newswire (Mon, 26-Jan 10:07 AM ET)
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alexandria
Business Wire (Mon, 26-Jan 9:27 AM ET)
PRNewswire (Mon, 26-Jan 4:29 AM ET)
PRNewswire (Mon, 26-Jan 4:28 AM ET)
PRNewswire (Mon, 26-Jan 2:29 AM ET)
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
Alexandria Real Estate Equities trades on the NYSE stock market under the symbol ARE.
As of February 6, 2026, ARE stock price climbed to $55.90 with 1,647,991 million shares trading.
ARE has a beta of 0.79, meaning it tends to be less sensitive to market movements. ARE has a correlation of 0.08 to the broad based SPY ETF.
ARE has a market cap of $9.69 billion. This is considered a Mid Cap stock.
Last quarter Alexandria Real Estate Equities reported $754 million in Revenue and $2.16 earnings per share. This beat revenue expectation by $13 million and exceeded earnings estimates by $1.12.
In the last 3 years, ARE traded as high as $168.73 and as low as $44.10.
The top ETF exchange traded funds that ARE belongs to (by Net Assets): VNQ, VTI, VOO, VB, RSP.
ARE has underperformed the market in the last year with a price return of -37.3% while the SPY ETF gained +15.1%. However, in the short term, ARE had mixed performance relative to the market. It has outperformed in the last 3 months, returning +6.5% vs +3.3% return in SPY. But in the last 2 weeks, ARE shares have been beat by the market, returning -6.3% compared to an SPY return of +0.2%.
ARE support price is $53.82 and resistance is $56.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARE shares will trade within this expected range on the day.